Carmell Therapeutics’ Product Pipeline

Both Product Candidates use the same Drug Substance

Carmell Therapeutics' Product Pipeline

BHA designated as combination product (Plasma-based Bioactive Material & βTCP) regulated as a biologic in the US and is designated as a Class III Medical Device in the EU.

THA is a similar formulation to BHA minus the βTCP and is regulated as a biologic in the US.

Note: Gray arrow designates “to be confirmed with regulatory body interaction”

*HEAL II is powered to demonstrate superiority vs. standard of care and could potentially serve as one of the two pivotal clinical studies needed for BLA approval in the US.

Notice: Undefined variable: notifyJs in /usr/www/users/carmell/site/templates/_includes/lib/ on line 1